{
  "ticker": "OPL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959076",
  "id": "02959076",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250617",
  "time": "0911",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250617/pdf/06ktcv7rfghzzf.pdf",
  "summary": "**Summary of ASX Announcement (Opyl Limited - 17 June 2025):**  \n\n- **Key Appointment**: Matt Hallam appointed as Chief Revenue Officer (CRO) to drive commercial growth for TrialKey.ai.  \n- **Compensation**: AUD $10,000/month (70% cash, 30% equity via standard ASX advisor arrangements).  \n- **Strategic Focus**: Expanding market partnerships in biopharma and clinical research sectors.  \n\n**No material capital markets or trading-impacting information identified.**",
  "usage": {
    "prompt_tokens": 863,
    "completion_tokens": 107,
    "total_tokens": 970,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-16T23:18:29.072795"
}